We collect cookies to analyze our website traffic and performance; we never collect any personal data. Cookie Policy
Accept
The Tycoon Herald
  • Trending
  • World
  • Politics
  • Business
    • Business
    • Economy
    • Real Estate
    • Money
    • Crypto / NFT
  • Innovation
  • Lifestyle
    • Lifestyle
    • Food
    • Travel
    • Fashion
    • Leadership
  • Health
  • Sports
  • Entertainment
Reading: BerGenBio Second Quarter Outcomes 2024: Strong medical and monetary progress By Investing.com
Sign In
The Tycoon HeraldThe Tycoon Herald
Font ResizerAa
Search
  • Trending
  • World
  • Politics
  • Business
    • Business
    • Economy
    • Real Estate
    • Money
    • Crypto / NFT
  • Innovation
  • Lifestyle
    • Lifestyle
    • Food
    • Travel
    • Fashion
    • Leadership
  • Health
  • Sports
  • Entertainment
Have an existing account? Sign In
Follow US
© Tycoon Herald. All Rights Reserved.
BerGenBio Second Quarter Outcomes 2024: Strong medical and monetary progress By Investing.com
The Tycoon Herald > Business > BerGenBio Second Quarter Outcomes 2024: Strong medical and monetary progress By Investing.com
Business

BerGenBio Second Quarter Outcomes 2024: Strong medical and monetary progress By Investing.com

Tycoon Herald
By Tycoon Herald 5 Min Read
Share
SHARE

BerGenBio Second Quarter Outcomes 2024: Strong medical and monetary progress By Investing.com

BERGEN, Norway, Aug. 21, 2024 /PRNewswire/ — BerGenBio ASA (OSE: BGBIO), a clinical-stage biopharmaceutical firm creating novel, selective AXL kinase inhibitors for extreme unmet medical wants, as we speak introduced monetary outcomes for the quarter and half 12 months ended June 30, 2024, and offered a enterprise replace.

Highlights, together with submit interval:

  • BGBC016 1L NSCLC STK11m examine continues to progress as deliberate. Enrollment within the Ph1b half accomplished. Knowledge Security Monitoring Board evaluate of information from the ultimate Ph1b dose cohort helps security and tolerability of the mix of bemcentinib with customary of care chemo/immunotherapy permitting initiation of the twond dose within the Ph2a half. All Ph2a websites have now been activated.
  • Progressive strategy established with main genomic AI supplier to speed up growth of bemcentinib. Established knowledge and regulatory collaboration with expertise firm Tempus AI (Nasdaq: TEM) to offer potential comparative medical knowledge from 1L STK11m NSCLC sufferers to assist within the analysis of BGBC016 outcomes.
  • Strengthened monetary place. Secured gross funding of NOK 138.9 million from warrant train in June 2024 securing funding into H2 2025. Monetary place of NOK 200.1 million finish of Q2 2024.
  • Secure money use. Continued decreased and stabilized working bills at NOK 90.5 million for first half 2024 in comparison with NOK 120.2 million in first half 2023. Working bills NOK 50.8 million in Q2 2024 in comparison with NOK 47.8 million in Q2 2023.

Martin Olin (NYSE:), Chief Government Officer of BerGenBio said:

“The BGBC016 clinical trial continued to progress well during the quarter. An independent review of the final cohort in the Ph1b part showed acceptable safety allowing initiation of the 2nd dose in the Ph2a part, and we completed the activation of the Ph2a sites. We now look forward to sharing preliminary efficacy data from the Ph2a portion of the study as they mature. During the quarter we strengthened our financial position which will, combined with our continuing cost discipline, fund our planned activities into the second half of 2025. The BGBC016 clinical trial is our highest priority, and we remain dedicated to unlocking the significant value potential in bemcentinib.”

Presentation and Monetary Report

The Q2 2024 Monetary report is hooked up to this inventory change announcement and the report and the Q2 2024 presentation can be found on the Firm’s web site https://www.bergenbio.com/buyers/financial-reports.

Webcast particulars

BerGenBio’s senior administration workforce will present a enterprise replace as we speak at 9:45 am CET. The presentation will webcast reside. To take part within the webcast, please use the next hyperlink:

https://channel.royalcast.com/landingpage/hegnarmedia/20240821_12/

A recording of the webcast can be obtainable at www.bergenbio.com within the Buyers/Monetary Stories part  (https://www.bergenbio.com/buyers/financial-reports) shortly afterwards.

Contacts

Martin Olin CEO,  BerGenBio ASA
[email protected]

Rune Skeie, CFO, BerGenBio ASA
[email protected]

Media Relations

Jan Lilleby[email protected]

About BerGenBio ASA

BerGenBio is a clinical-stage biopharmaceutical firm centered on creating transformative medicine concentrating on AXL as a possible cornerstone of remedy for aggressive ailments, together with most cancers and extreme respiratory infections. The Firm is targeted on its proprietary lead candidate, bemcentinib, a probably first-in-class selective AXL inhibitor in medical growth for STK11 mutated NSCLC and preclinical growth for extreme respiratory infections.

BerGenBio is predicated in Bergen, Norway, with a subsidiary in Oxford, UK. The corporate is listed on the Oslo Inventory Trade (ticker: BGBIO). For extra data, go to www.bergenbio.com

Ahead trying statements

This announcement could include forward-looking statements, which as such will not be historic information, however are based mostly upon varied assumptions, lots of that are based mostly, in flip, upon additional assumptions. These assumptions are inherently topic to important identified and unknown dangers, uncertainties, and different essential components. Such dangers, uncertainties, contingencies and different essential components may trigger precise occasions to vary materially from the expectations expressed or implied on this announcement by such forward-looking statements.

This data is taken into account to be inside data pursuant to the EU Market Abuse Regulation and topic to the disclosure necessities pursuant to part 5-12 of the Norwegian Securities Buying and selling Act.

This data was delivered to you by Cision http://information.cision.com

https://information.cision.com/bergenbio-asa/r/bergenbio-second-quarter-results-2024–solid-clinical-and-financial-progress,c4026515

The next information can be found for obtain:

https://mb.cision.com/Public/15728/4026515/a85d82bb3b88312e.pdf

Q2 and half 12 months 2024 Monetary report

 

You Might Also Like

Joseph Safina’s Driven Becomes Amazon Bestseller, Blending High Finance with High Speeds

Fashion Designer Hyeonseo Irene Park: Redefining Menswear Through Originality and Collaboration

From Pattaya to the World: Bryan Flowers’ Unstoppable Rise as a Global Entrepreneur

Astana International Forum 2025: “Connecting Minds, Shaping the Future”

Investment success: GP Fatih Marketing Research Co LLC and the gold dream in Africa

TAGGED:BerGenBioclinicalFinancialInvesting.comprogressQuarterresultssolid
Share This Article
Facebook Twitter Email Copy Link Print
UK housebuilders comply with pay £100mn after competitors probe
Economy

UK housebuilders comply with pay £100mn after competitors probe

Keep knowledgeable with free updatesMerely signal as much as the Property sector myFT Digest -- delivered on to your inbox.Seven of the UK’s greatest housebuilders have agreed to pay a…

By Tycoon Herald 2 Min Read
Anthony Yarde desires Dmitry Bivol combat after David Benavidez: ‘I have no fear of any man on this planet’
July 9, 2025
Angel Reese Slaps Clipboard Out Of Coach’s Hand Throughout Sky Loss
July 9, 2025
Impostor makes use of AI to impersonate Rubio and get in touch with overseas and US officers
July 9, 2025
Breaking Down the Avenue Fashion Look That’s Taking Over Tokyo | FashionBeans
July 9, 2025

You Might Also Like

Gaza residents stream dwelling to the north after hostage breakthrough By Reuters
Business

Gaza residents stream dwelling to the north after hostage breakthrough By Reuters

By Tycoon Herald 6 Min Read
Greenback positive factors on tariffs fears; euro seems to be to ECB assembly By Investing.com
Business

Greenback positive factors on tariffs fears; euro seems to be to ECB assembly By Investing.com

By Tycoon Herald 5 Min Read
EQT Real Estate acquires 12-building logistics assemblage positioned in key Northern Italian submarkets By Investing.com
Business

EQT Real Estate acquires 12-building logistics assemblage positioned in key Northern Italian submarkets By Investing.com

By Tycoon Herald 4 Min Read

More Popular from Tycoon Herald

MEET THE FATHER OF COADUNATE ECONOMIC MODEL
BusinessTrending

MEET THE FATHER OF COADUNATE ECONOMIC MODEL

By Tycoon Herald 2 Min Read
Woman Sentenced to 7 Days in Jail for Walking in Yellowstone’s Thermal Area

Woman Sentenced to 7 Days in Jail for Walking in Yellowstone’s Thermal Area

By Tycoon Herald
Empowering Fintech Innovation: Swiss Options Partners with Stripe to Transform Digital Payments
InnovationTrending

Empowering Fintech Innovation: Swiss Options Partners with Stripe to Transform Digital Payments

By Tycoon Herald 7 Min Read
World

Greetings from Warsaw, Poland, the place the flags are flying forward of a key election

Far-Flung Postcards is a weekly sequence wherein NPR's worldwide correspondents share snapshots of moments from their…

By Tycoon Herald
Entertainment

Patrick Mahomes Sr., John Rocker Swap Insults After New Orleans Mud-Up

Patrick Mahomes Sr., John Rocker Commerce Insults After NOLA Mud-Up ... 'Lanky Ass Clown' Printed February…

By Tycoon Herald
Trending

U.S. Blew Up a C.I.A. Post Used to Evacuate At-Risk Afghans

A controlled detonation by American forces that was heard throughout Kabul has destroyed Eagle Base, the…

By Tycoon Herald
Leadership

Northern Lights: 17 Best Places To See Them In 2021

Who doesn’t dream of seeing the northern lights? According to a new survey conducted by Hilton, 59% of Americans…

By Tycoon Herald
Real Estate

Exploring Bigfork, Montana: A Little Town On A Big Pond

Bigfork, Montana, offers picturesque paradise in the northern wilderness. National Parks Realty With the melting of…

By Tycoon Herald
Leadership

Leaders Need To Know Character Could Be Vital For Corporate Culture

Disney's unique culture encourages young employees to turn up for work with smiles on their faces.…

By Tycoon Herald
The Tycoon Herald

Tycoon Herald: Your instant connection to breaking stories and live updates. Stay informed with our real-time coverage across politics, tech, entertainment, and more. Your reliable source for 24/7 news.

Company

  • About Us
  • Newsroom Policies & Standards
  • Diversity & Inclusion
  • Careers
  • Media & Community Relations
  • WP Creative Group
  • Accessibility Statement

Contact Us

  • Contact Us
  • Contact Customer Care
  • Advertise
  • Licensing & Syndication
  • Request a Correction
  • Contact the Newsroom
  • Send a News Tip
  • Report a Vulnerability

Terms of Use

  • Digital Products Terms of Sale
  • Terms of Service
  • Privacy Policy
  • Cookie Settings
  • Submissions & Discussion Policy
  • RSS Terms of Service
  • Ad Choices
© Tycoon Herald. All Rights Reserved.
Welcome Back!

Sign in to your account

Lost your password?